Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-centre trial of patients' ability to safely self-select sildenafil 50 mg for erectile dysfunction
2018-002597-41Phase 4Completed
- Sponsor
- Adamed Pharma
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sildenafil in erectile dysfunction (ED), sponsored by Adamed Pharma. Primary endpoint: Safe self-selection of sildenafil 50 mg. Started Oct 2018; status: completed.
02
Drugs
sildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2018-002597-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002597-41.